Induction of oxidative stress by bisphenol A and its pleiotropic effects

Environmental and Molecular Mutagenesis - Tập 58 Số 2 - Trang 60-71 - 2017
Natalie R. Gassman1
1University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, 36604-1405

Tóm tắt

Bisphenol A (BPA) has become a target of intense public scrutiny since concerns about its association with human diseases such as obesity, diabetes, reproductive disorders, and cancer have emerged. BPA is a highly prevalent chemical in consumer products, and human exposure is thought to be ubiquitous. Numerous studies have demonstrated its endocrine disrupting properties and attributed exposure with cytotoxic, genotoxic, and carcinogenic effects; however, the results of these studies are still highly debated and a consensus about BPA's safety and its role in human disease has not been reached. One of the contributing factors is a lack of molecular mechanisms or modes of action that explain the diverse and pleiotropic effects observed after BPA exposure. The increase in BPA research seen over the last ten years has resulted in more studies that examine molecular mechanisms and revealed links between BPA‐induced oxidative stress and human disease. Here, a review of the current literature examining BPA exposure and the induction of reactive oxygen species (ROS) or oxidative stress will be provided to examine the landscape of the current BPA literature and provide a framework for understanding how induction of oxidative stress by BPA may contribute to the pleiotropic effects observed after exposure. Environ. Mol. Mutagen. 58:60–71, 2017. © 2017 Wiley Periodicals, Inc.

Từ khóa


Tài liệu tham khảo

10.1177/1559325815610582

10.1073/pnas.93.24.13629

10.1073/pnas.1010386107

10.1016/j.mce.2011.12.012

10.1016/j.mam.2006.07.001

10.1016/j.envres.2015.11.029

10.1006/bbrc.1995.1678

10.1002/em.2850260109

10.1007/s00204-011-0721-2

10.1016/j.tox.2008.04.002

10.3109/15376516.2012.753969

10.1016/j.reprotox.2015.12.004

10.1016/j.jprot.2010.02.020

10.1016/S0300-483X(03)00056-8

10.1002/iub.370

10.1002/iub.130

10.1016/j.chemosphere.2010.07.048

10.1002/iub.376

10.1002/bdrb.20147

10.1007/s00204-014-1301-z

10.1021/tx400036v

10.1016/j.toxlet.2015.03.001

10.1016/S0300-483X(02)00597-8

10.1016/j.bbagrm.2012.06.002

10.1177/1559325815598308

10.1093/carcin/bgs379

10.1155/2012/645460

10.3109/01480545.2011.644561

10.1007/s12672-010-0015-9

10.1093/toxsci/kfh054

EPA(1993) Bisphenol A. (CASRN 80‐05‐7). Integrated Risk Information System (IRIS).

10.1289/ehp.00108723

Fernandez SV, 2012, Expression and DNA methylation changes in human breast epithelial cells after bisphenol A exposure, Int J Oncol, 41, 369

10.2478/10004-1254-64-2013-2319

10.1016/j.envpol.2010.06.040

10.1289/EHP237

10.1371/journal.pone.0118819

10.1002/9781119023647.ch12

10.1016/j.bbagen.2014.05.018

10.1016/j.toxlet.2014.01.035

10.1016/j.toxlet.2015.09.021

10.1093/carcin/bgr196

Gore AC, 2015, Executive summary to EDC‐2: The endocrine society's second scientific statement on endocrine‐disrupting chemicals. Endocr, Rev, 36, 593

Hassan ZK, 2012, Bisphenol A induces hepatotoxicity through oxidative stress in rat model. Oxid, Med Cell Longev, 2012, 194829

10.1016/j.tiv.2012.03.017

10.1016/j.mrgentox.2009.07.011

10.1016/j.fct.2011.03.032

10.1016/j.lfs.2003.07.060

10.1016/S0013-9351(03)00062-8

10.1016/S0142-9612(00)00088-0

10.1007/s00244-015-0199-7

10.1016/j.freeradbiomed.2011.09.030

10.1007/s11892-014-0494-0

10.1007/978-3-642-29687-1_4

10.4161/23273747.2014.995003

10.1016/j.mehy.2010.03.002

10.1016/j.envres.2015.06.013

10.1016/j.canlet.2009.09.005

10.1289/ehp.11788

10.1002/tox.22239

10.3109/10715761003667554

10.1016/j.steroids.2012.02.019

10.1016/j.ygcen.2014.11.003

10.3390/ijerph110707537

10.3109/15376516.2015.1056395

10.3346/jkms.2012.27.6.644

10.1093/toxsci/68.1.184

10.1016/j.tox.2010.02.008

10.1007/s002040050659

NTP(2008) NTP‐CERHR monograph on the potential human reproductive and developmental effects of bisphenol A.NTP CERHR MON v vii‐ix 1‐64 passim.

10.1093/toxsci/kfi278

10.1093/toxsci/kfq268

10.1289/ehp.1409199

10.1021/acs.chemrestox.5b00093

10.1371/journal.pone.0151618

10.1016/j.toxlet.2014.07.001

10.1155/2014/761264

10.1016/j.envint.2013.12.007

10.1016/j.reprotox.2013.08.008

10.1016/j.jsbmb.2011.05.002

10.1016/j.fct.2010.05.051

10.1016/j.reprotox.2013.05.010

10.1016/j.reprotox.2015.09.006

10.1016/j.envres.2005.05.004

10.1016/j.tiv.2015.09.009

10.1016/j.mrgentox.2011.12.023

10.1096/fj.13-240465

10.1136/jech-2016-207841

10.1016/j.biocel.2006.07.001

10.1289/ehp.0901716

10.1590/S1413-81232012000200015

10.1210/er.2011-1050

10.1016/j.reprotox.2007.07.010

10.1515/reveh-2012-0034

10.1111/andr.12219

10.1186/1476-069X-12-26

10.1021/tx025548t

10.1016/j.mce.2012.01.001

10.2131/jts.38.285

10.1016/j.ijheh.2014.11.001

10.1016/j.steroids.2005.03.002

10.1080/15592294.2015.1107694

10.1210/en.2005-1159

10.1016/j.reprotox.2007.05.010

10.1016/j.mrgentox.2013.01.005

10.1016/j.mrgentox.2014.04.019

10.1016/j.envres.2009.04.014

10.1016/j.mrgentox.2011.06.007

10.1371/journal.pone.0098635

10.1271/bbb.65.1444

10.1021/acs.est.6b00032

10.1016/j.reprotox.2015.05.012

10.1007/s10753-014-9971-5